The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. More Info:- https://www.imarcgroup.com/copd-asthma-devices-market

1. Global COPD and
Asthma Devices Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "COPD and Asthma
Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2024-2032," the global COPD and asthma devices market size
reached US$ 45.7 Billion in 2023.
COPD and asthma devices are medical equipment designed to help patients
manage their symptoms of chronic obstructive pulmonary disease (COPD) and
asthma. They provide the user with data on respiratory functions, along with
therapy to aid in controlling their symptoms. COPD devices help in monitoring
lung function, tracking medications, detecting early signs of exacerbations, and
providing reminders for treatments.
On the other hand, asthma devices provide data on air quality levels and
monitor peak flow measurements and other asthma triggers. The demand for
COPD and asthma devices is continually increasing as they improve the quality
of life of the patients by providing the user with the tools they need to manage
their condition better.
Request for a PDF sample of this report: https://www.imarcgroup.com/copd-
asthma-devices-market/requestsample

4. Report Description
Global COPD and Asthma Devices Market Trends:
The rising prevalence of chronic diseases among the masses majorly drives the global market. This can be
supported by the growing pollution levels and the escalating number of cigarette smokers across the globe.
Coupled with this, the increasing incidences of chronic respiratory diseases (CRDs), including chronic obstructive
pulmonary disease (COPD), lung disorders, pulmonary hypertension (PH), bronchial asthma, and cystic fibrosis
among individuals, are catalyzing the demand for COPD and asthma devices. Apart from this, the occupational
exposure to dust in forestry, mining, and agricultural sectors is also accelerating the demand for effective airway
management devices, thereby propelling the market.
In addition, the augmenting adoption of connected medical devices among healthcare professionals to ensure that
patients receive the best care and consultation possible, regardless of the circumstance, is acting as a growth-
inducing factor. Moreover, various leading manufacturers are developing more effective and efficient COPD and
asthma devices to improve the efficiency of medication management, along with continuous developments in
home-based COPD and asthma treatments, thus creating a positive market outlook. Some of the other factors
driving the market include the rising healthcare expenditure and growing reimbursement schemes offered by
health insurance companies.
Looking forward, the market is anticipated to reach a value of US$ 69.5 Billion by 2032, exhibiting a CAGR
of 4.6% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/copd-asthma-devices-market

5. Report
Segmentation
Breakup by Product:
• Inhalers
o Drug Powdered Inhalers (DPIs)
o Metered Dose Inhalers (MDIs)
o Soft Mist Inhalers
• Nebulizers
o Compressor Nebulizers
o Ultrasonic Nebulizers
o Mesh Nebulizers
Breakup by Indication:
• Asthma
• COPD
Breakup by Distribution Channel:
• Retail Pharmacies

6. Report
Segmentation
• Hospitals
• Online Pharmacies
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Adherium Limited
• Aristopharma Ltd.
• AstraZeneca PLC
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cohero Health Inc.
• Koninklijke Philips N.V.
• Omron Corporation
• Pari Respiratory Equipment Inc.
• Recipharm AB
• Verona Pharma plc.

8. Key Questions
Answered in
the Report
What was the size of the global COPD and asthma devices market
in 2023?
What is the expected growth rate of the global COPD and asthma
devices market during 2024-2032?
What are the key factors driving the global COPD and asthma
devices market?
What has been the impact of COVID-19 on the global COPD and
asthma devices market?
What is the breakup of the global COPD and asthma devices market
based on the product?
What is the breakup of the global COPD and asthma devices market
based on the indication?
What is the breakup of the global COPD and asthma devices market
based on distribution channel?
What are the key regions in the global COPD and asthma devices
market?
Who are the key players/companies in the global COPD and asthma
devices market?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global COPD and Asthma Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Inhalers
6.1.1 Mark et Trends
6.1.2 Key Segments
6.1.2.1 Drug Powdered Inhalers (DPIs)
6.1.2.2 Metered Dose Inhalers (MDIs)
6.1.2.3 Soft Mist Inhalers
6.1.3 Mark et Forecast
6.2 Nebulizers
6.2.1 Mark et Trends
6.2.2 Key Segments

10. Table of
Contents
6.2.2.1 Compressor Nebulizers
6.2.2.2 Ultrasonic Nebulizers
6.2.2.3 Mesh Nebulizers
6.2.3 Mark et Forecast
7 Market Breakup by Indication
7.1 Asthma
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 COPD
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
8 Market Breakup by Distribution Channel
8.1 Retail Pharmacies
8.1.1 Mark et Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Online Pharmacies
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Mark et Trends
9.1.1.2 Mark et Forecast
9.1.2 Canada
9.1.2.1 Mark et Trends
9.1.2.2 Mark et Forecast
9.2 Asia-Pacific
For more information, visit :
https://www.imarcgroup.com/copd -asthma-devices-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com